𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The Interpretation of Libet's Results on the Timing of Conscious Events: A Commentary

✍ Scribed by Gilberto Gomes

Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
44 KB
Volume
11
Category
Article
ISSN
1053-8100

No coin nor oath required. For personal study only.

✦ Synopsis

A commentary on articles by Klein, Pockett, and Trevena and Miller, in this issue, is given. Average shift in the point of subjective equality (PSE), calculated by Klein on Libet's data, and corresponding change in mean shift, calculated by Libet et al. (1983), may be "corrected," taking as a reference point the end of the minimum train duration. Values obtained, if significant, indicate a latency for conscious sensation of the skin stimulus of at least 230 ms. Pockett's main conclusions are favored, but her explanation of peripheral-lemniscal couplings is found to be unconvincing. Trevena and Miller's article unsuccessfully tries to rescue a dualist interactionist view. Libet's method of timing intentions is thoroughly criticized.

πŸ“œ SIMILAR VOLUMES

Libet's Timing of Mental Events: Comment
Libet's Timing of Mental Events: Commentary on the Commentaries
✍ Stanley Klein πŸ“‚ Article πŸ“… 2002 πŸ› Elsevier Science 🌐 English βš– 39 KB

This issue of Consciousness and Cognition presents four target articles and eight commentaries on the target articles. The present article presents comments on those commentaries, grouped into backward referral and volition categories. Regarding backward referral: (1) I disagree with my fellow comm

Interpreting the results of Parkinson's
Interpreting the results of Parkinson's disease clinical trials: Time for a change
✍ Nick H. G. Holford; John G. Nutt πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 199 KB πŸ‘ 1 views

## Abstract Randomized clinical trials testing putative disease‐modifying agents in Parkinson's disease (PD) have yielded controversial results that have not influenced evidence‐based recommendations for the treatment of PD. We argue that the failure of these clinical trials may be linked to end po